机构

• 合肥物质科学研究院 [7]
• 上海药物研究所 [3]
• 长春光学精密机械与物... [1]
• 过程工程研究所 [1]
• 上海应用物理研究所 [1]
• 自动化研究所 [1]
• 更多

采集方式

• OAI收割 [14]

内容类型

• 期刊论文 [14]

发表日期

• 2020 [14]

学科主题

筛选

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 发表日期：2020     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth 期刊论文  OAI收割 CANCER LETTERS, 2020, 卷号: 493 作者:  Hu, Lulu;  Shen, Dachuan;  Liang, Dapeng;  Shi, Ji   |  收藏  |  浏览/下载：68/0  |  提交时间：2020/11/30 Glioblastoma (GBM)  EGFR  EGFRvIII  TRIP13  Osimertinib   Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions 期刊论文  OAI收割 THORACIC CANCER, 2020 作者:  Chen, Kaiyan;  Pan, Guoqiang;  Cheng, Guoping;  Zhang, Fanrong;  Xu, Yanjun   |  收藏  |  浏览/下载：75/0  |  提交时间：2020/12/28 EGFR  HER2  immunotherapy  NSCLC  PD‐  L1   Construction of a novel bispecific fusion protein to enhance targeting for pancreatic cancer imaging 期刊论文  OAI收割 BIOMATERIALS, 2020, 期号: 255, 页码: 120161 作者:  Wang, Qian;  Yan, Hao;  Wang, Zihua;  Li, Zhangfu;  Li, Dan   |  收藏  |  浏览/下载：43/0  |  提交时间：2020/09/07 Bispecific targeting  Fusion protein  Antibody  Molecular imaging  Pancreatic cancer   Graphene oxide-based nanocomposite enabled highly efficient targeted synergistic therapy for colorectal cancer 期刊论文  OAI收割 COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2020, 卷号: 593, 页码: 8 作者:  Qiu, Zhichao;  Hu, Jing;  Li, Ziwei;  Yang, Xiaoxue;  Hu, Jun   |  收藏  |  浏览/下载：31/0  |  提交时间：2020/05/21 Graphene oxide  GE11  Drug delivery  GSH  Chemo-photothermal therapy   Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020 作者:     |  收藏  |  浏览/下载：21/0  |  提交时间：2020/11/26 glioblastoma  osimertinib  temozolamide  MAPK-signaling pathway  MNK  eukaryotic translation initiation factor 4E   Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun   |  收藏  |  浏览/下载：59/0  |  提交时间：2020/10/26 tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)   Design and synthesis of selective degraders of EGFR(L858R/T790M) mutant 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 卷号: 192, 页码: 14 作者:  Zhang, Xin   |  收藏  |  浏览/下载：68/0  |  提交时间：2020/07/01 Epidermal growth factor receptor (EGFR)  Resistance  Proteolysis targeting chimera (PROTAC)  Protein degradation   PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文  OAI收割 LUNG CANCER, 2020, 卷号: 142 作者:  Chen, Kaiyan;  Cheng, Guoping   |  收藏  |  浏览/下载：70/0  |  提交时间：2020/11/26 Uncommon EGFR  Non-small cell lung cancer  PD-L1  T cell  Immunotherapy   EGFR exon 20 insertion mutations in non-small cell lung cancer 期刊论文  OAI收割 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Wang, Fenfang;  Li, Chenghui;  Wu, Qihuan;  Lu, Hongyang   |  收藏  |  浏览/下载：54/0  |  提交时间：2020/11/26 EGFR exon 20 insertion mutations  non-small cell lung cancer (NSCLC)  EGFR-TKIs  structural features  clinical features  treatment  prognosis   Alflutinib (AST2818), primarily metabolized by CYP3A4, is a potent CYP3A4 inducer 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11 作者:  Liu, Xiao-yun;  Guo, Zi-tao;  Chen, Zhen-dong;  Zhang, Yi-fan;  Zhou, Jia-lan   |  收藏  |  浏览/下载：97/0  |  提交时间：2020/07/01 alflutinib  AST5902  metabolism  enzyme induction  drug-drug interaction